News — AI supercycle headlines

Barrons.com18h agoneutral

How Hantavirus Made Moderna a Must-Own Stock Again

The stock has rapidly outpaced the broader market, but the long-term implications of the hantavirus are unclear.

MRK MRNA ^GSPC

Barrons.com1d agoneutral

These Stocks Are Today’s Movers: CoreWeave, Trade Desk, Cloudflare, Akamai, Block, and More

CoreWeave drops after missing analysts’ earnings target, while Trade Desk plummets on weak revenue guidance.

Barrons.com1d agoneutral

Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied

Evercore ISI analysts cautioned investors, writing Thursday that “with regards to current headlines, we see no meaningful revenue opportunity.”

MRNA RCL

MarketBeat2d agoneutral

Moderna Shareholders OK Directors, Executive Pay Votes and Ernst & Young as 2026 Auditor at AGM

Moderna (NASDAQ:MRNA) shareholders approved all four management proposals at the company’s 2026 Annual Meeting of Shareholders, including the re-election of two directors, advisory votes related to executive compensation, and the ratification of Ernst & Young as the company’s independent auditor

MRNA ^GSPC

Barchart2d agoneutral

Is Wall Street Bullish or Bearish on Moderna Stock?

Moderna has notably outperformed the broader market over the past year, yet Wall Street analysts maintain a cautious outlook about the stock’s prospects.

MRNA

The Daily Upside3d agoneutral

Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles

Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, respectively.

MRNA PFE

Entrepreneur3d agoneutral

Chicken or the Egg? Why We Need to Rethink Data and Funding in Startups

Raising capital while still building the data needed to validate an idea is often one of the biggest hurdles for start-ups.

MRNA PFE

MT Newswires4d agoneutral

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks declined Monday afternoon, with the NYSE Health Care Index and the State Street H

AMGN LLY MRNA

MT Newswires4d agoneutral

Moderna Sees Progress Across Cancer Vaccine, Infectious Disease Pipeline, RBC Says

Moderna (MRNA) is showing continued advancement across its pipeline, with progress in cancer vaccine

MRNA

24/7 Wall St.4d agoneutral

Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push into obesity drugs. Moderna leaned on cost cuts and international expansion to soften a steep COVID revenue cliff. Two very different pharma stories, both shaped by life ... Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

MRNA PFE